Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – eBioscience and Australian firm Anteo Diagnostics today announced a licensing deal covering Anteo's Mix&Go technology.

Anteo will supply eBioscience with its Mix&Go product for the manufacture of reagents. In return it will receive an initial upfront payment from eBioscience, fixed revenues for Mix&Go reagents supplied, and royalties on the sale of products by eBioscience using Mix&Go.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.